Here, using data extracted from the TCGA database, we identified a novel lncRNA, ACVR2B-AS1, whose upregulation is common in liver cancer, and found that higher ACVR2B-AS1 expression predicted poorer OS and RFS in liver cancer patients. The gene discussed is ACVR2B; the disease is liver cancer.